aluates Reports

$ 0.0

Automative

Global Female Sexual Dysfunction Treatment Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-14G442

Global Female Sexual Dysfunction Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Female Sexual Dysfunction Treatment Market Research Report 2024

Code: QYRE-Auto-14G442

Report

January 2024

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AMAG Pharmaceuticals Inc

Duchesnay Inc.

Emotional Brain BV

Novo Nordisk AS

Sprout Pharmaceuticals Inc.

Female Sexual Dysfunction Treatment Market Size

The global Female Sexual Dysfunction Treatment market was valued at US$ 122.6 million in 2023 and is anticipated to reach US$ 819.4 million by 2030, witnessing a CAGR of 30.6% during the forecast period 2024-2030.

Female Sexual Dysfunction Treatment Market

Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Female Sexual Dysfunction Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Sexual Dysfunction Treatment.

Report Scope

The Female Sexual Dysfunction Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Female Sexual Dysfunction Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Female Sexual Dysfunction Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Female Sexual Dysfunction Treatment Market Report

Report Metric	Details
Report Name	Female Sexual Dysfunction Treatment Market
Accounted market size in 2023	US$ 122.6 million
Forecasted market size in 2030	US$ 819.4 million
CAGR	30.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Non-hormonal Therapy Hormonal Therapy
Segment by Application	Sexual Desire Disorders Sexual Arousal Disorders Orgasm Disorders Sexual Pain Disorders Post-orgasmic Diseases Pelvic Floor Dysfunction Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AMAG Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV, Novo Nordisk AS, Sprout Pharmaceuticals Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Female Sexual Dysfunction Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Female Sexual Dysfunction Treatment Market growing?

Ans: The Female Sexual Dysfunction Treatment Market witnessing a CAGR of 30.6% during the forecast period 2024-2030.

What is the Female Sexual Dysfunction Treatment Market size in 2030?

Ans: The Female Sexual Dysfunction Treatment Market size in 2030 will be US$ 819.4 million.

Who are the main players in the Female Sexual Dysfunction Treatment Market report?

Ans: The main players in the Female Sexual Dysfunction Treatment Market are AMAG Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV, Novo Nordisk AS, Sprout Pharmaceuticals Inc.

What are the Application segmentation covered in the Female Sexual Dysfunction Treatment Market report?

Ans: The Applications covered in the Female Sexual Dysfunction Treatment Market report are Sexual Desire Disorders, Sexual Arousal Disorders, Orgasm Disorders, Sexual Pain Disorders, Post-orgasmic Diseases, Pelvic Floor Dysfunction, Other

What are the Type segmentation covered in the Female Sexual Dysfunction Treatment Market report?

Ans: The Types covered in the Female Sexual Dysfunction Treatment Market report are Non-hormonal Therapy, Hormonal Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Non-hormonal Therapy

1.2.3 Hormonal Therapy

1.3 Market by Application

1.3.1 Global Female Sexual Dysfunction Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Sexual Desire Disorders

1.3.3 Sexual Arousal Disorders

1.3.4 Orgasm Disorders

1.3.5 Sexual Pain Disorders

1.3.6 Post-orgasmic Diseases

1.3.7 Pelvic Floor Dysfunction

1.3.8 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Female Sexual Dysfunction Treatment Market Perspective (2019-2030)

2.2 Female Sexual Dysfunction Treatment Growth Trends by Region

2.2.1 Global Female Sexual Dysfunction Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Female Sexual Dysfunction Treatment Historic Market Size by Region (2019-2024)

2.2.3 Female Sexual Dysfunction Treatment Forecasted Market Size by Region (2025-2030)

2.3 Female Sexual Dysfunction Treatment Market Dynamics

2.3.1 Female Sexual Dysfunction Treatment Industry Trends

2.3.2 Female Sexual Dysfunction Treatment Market Drivers

2.3.3 Female Sexual Dysfunction Treatment Market Challenges

2.3.4 Female Sexual Dysfunction Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Female Sexual Dysfunction Treatment Players by Revenue

3.1.1 Global Top Female Sexual Dysfunction Treatment Players by Revenue (2019-2024)

3.1.2 Global Female Sexual Dysfunction Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Female Sexual Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Female Sexual Dysfunction Treatment Revenue

3.4 Global Female Sexual Dysfunction Treatment Market Concentration Ratio

3.4.1 Global Female Sexual Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Female Sexual Dysfunction Treatment Revenue in 2023

3.5 Female Sexual Dysfunction Treatment Key Players Head office and Area Served

3.6 Key Players Female Sexual Dysfunction Treatment Product Solution and Service

3.7 Date of Enter into Female Sexual Dysfunction Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Female Sexual Dysfunction Treatment Breakdown Data by Type

4.1 Global Female Sexual Dysfunction Treatment Historic Market Size by Type (2019-2024)

4.2 Global Female Sexual Dysfunction Treatment Forecasted Market Size by Type (2025-2030)

5 Female Sexual Dysfunction Treatment Breakdown Data by Application

5.1 Global Female Sexual Dysfunction Treatment Historic Market Size by Application (2019-2024)

5.2 Global Female Sexual Dysfunction Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Female Sexual Dysfunction Treatment Market Size (2019-2030)

6.2 North America Female Sexual Dysfunction Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Female Sexual Dysfunction Treatment Market Size by Country (2019-2024)

6.4 North America Female Sexual Dysfunction Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Female Sexual Dysfunction Treatment Market Size (2019-2030)

7.2 Europe Female Sexual Dysfunction Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Female Sexual Dysfunction Treatment Market Size by Country (2019-2024)

7.4 Europe Female Sexual Dysfunction Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Female Sexual Dysfunction Treatment Market Size (2019-2030)

8.2 Asia-Pacific Female Sexual Dysfunction Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Female Sexual Dysfunction Treatment Market Size (2019-2030)

9.2 Latin America Female Sexual Dysfunction Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Female Sexual Dysfunction Treatment Market Size by Country (2019-2024)

9.4 Latin America Female Sexual Dysfunction Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Female Sexual Dysfunction Treatment Market Size (2019-2030)

10.2 Middle East & Africa Female Sexual Dysfunction Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AMAG Pharmaceuticals Inc.

11.1.1 AMAG Pharmaceuticals Inc. Company Detail

11.1.2 AMAG Pharmaceuticals Inc. Business Overview

11.1.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Introduction

11.1.4 AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2019-2024)

11.1.5 AMAG Pharmaceuticals Inc. Recent Development

11.2 Duchesnay Inc.

11.2.1 Duchesnay Inc. Company Detail

11.2.2 Duchesnay Inc. Business Overview

11.2.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Introduction

11.2.4 Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business (2019-2024)

11.2.5 Duchesnay Inc. Recent Development

11.3 Emotional Brain BV

11.3.1 Emotional Brain BV Company Detail

11.3.2 Emotional Brain BV Business Overview

11.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Introduction

11.3.4 Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business (2019-2024)

11.3.5 Emotional Brain BV Recent Development

11.4 Novo Nordisk AS

11.4.1 Novo Nordisk AS Company Detail

11.4.2 Novo Nordisk AS Business Overview

11.4.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Introduction

11.4.4 Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business (2019-2024)

11.4.5 Novo Nordisk AS Recent Development

11.5 Sprout Pharmaceuticals Inc.

11.5.1 Sprout Pharmaceuticals Inc. Company Detail

11.5.2 Sprout Pharmaceuticals Inc. Business Overview

11.5.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Introduction

11.5.4 Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2019-2024)

11.5.5 Sprout Pharmaceuticals Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

AMAG Pharmaceuticals Inc

Duchesnay Inc.

Emotional Brain BV

Novo Nordisk AS

Sprout Pharmaceuticals Inc.

List of Tables

Table 1. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Non-hormonal Therapy

Table 3. Key Players of Hormonal Therapy

Table 4. Global Female Sexual Dysfunction Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Female Sexual Dysfunction Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Female Sexual Dysfunction Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Female Sexual Dysfunction Treatment Market Share by Region (2019-2024)

Table 8. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Female Sexual Dysfunction Treatment Market Share by Region (2025-2030)

Table 10. Female Sexual Dysfunction Treatment Market Trends

Table 11. Female Sexual Dysfunction Treatment Market Drivers

Table 12. Female Sexual Dysfunction Treatment Market Challenges

Table 13. Female Sexual Dysfunction Treatment Market Restraints

Table 14. Global Female Sexual Dysfunction Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Female Sexual Dysfunction Treatment Market Share by Players (2019-2024)

Table 16. Global Top Female Sexual Dysfunction Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Sexual Dysfunction Treatment as of 2023)

Table 17. Ranking of Global Top Female Sexual Dysfunction Treatment Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Female Sexual Dysfunction Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Female Sexual Dysfunction Treatment Product Solution and Service

Table 21. Date of Enter into Female Sexual Dysfunction Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Female Sexual Dysfunction Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global Female Sexual Dysfunction Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2019-2024)

Table 29. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2025-2030)

Table 31. North America Female Sexual Dysfunction Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Female Sexual Dysfunction Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Female Sexual Dysfunction Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Female Sexual Dysfunction Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Female Sexual Dysfunction Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Female Sexual Dysfunction Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Female Sexual Dysfunction Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Female Sexual Dysfunction Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Female Sexual Dysfunction Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Female Sexual Dysfunction Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Female Sexual Dysfunction Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. AMAG Pharmaceuticals Inc. Company Detail

Table 47. AMAG Pharmaceuticals Inc. Business Overview

Table 48. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product

Table 49. AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2019-2024) & (US$ Million)

Table 50. AMAG Pharmaceuticals Inc. Recent Development

Table 51. Duchesnay Inc. Company Detail

Table 52. Duchesnay Inc. Business Overview

Table 53. Duchesnay Inc. Female Sexual Dysfunction Treatment Product

Table 54. Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business (2019-2024) & (US$ Million)

Table 55. Duchesnay Inc. Recent Development

Table 56. Emotional Brain BV Company Detail

Table 57. Emotional Brain BV Business Overview

Table 58. Emotional Brain BV Female Sexual Dysfunction Treatment Product

Table 59. Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business (2019-2024) & (US$ Million)

Table 60. Emotional Brain BV Recent Development

Table 61. Novo Nordisk AS Company Detail

Table 62. Novo Nordisk AS Business Overview

Table 63. Novo Nordisk AS Female Sexual Dysfunction Treatment Product

Table 64. Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business (2019-2024) & (US$ Million)

Table 65. Novo Nordisk AS Recent Development

Table 66. Sprout Pharmaceuticals Inc. Company Detail

Table 67. Sprout Pharmaceuticals Inc. Business Overview

Table 68. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product

Table 69. Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2019-2024) & (US$ Million)

Table 70. Sprout Pharmaceuticals Inc. Recent Development

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Female Sexual Dysfunction Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Female Sexual Dysfunction Treatment Market Share by Type: 2023 VS 2030

Figure 3. Non-hormonal Therapy Features

Figure 4. Hormonal Therapy Features

Figure 5. Global Female Sexual Dysfunction Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Female Sexual Dysfunction Treatment Market Share by Application: 2023 VS 2030

Figure 7. Sexual Desire Disorders Case Studies

Figure 8. Sexual Arousal Disorders Case Studies

Figure 9. Orgasm Disorders Case Studies

Figure 10. Sexual Pain Disorders Case Studies

Figure 11. Post-orgasmic Diseases Case Studies

Figure 12. Pelvic Floor Dysfunction Case Studies

Figure 13. Other Case Studies

Figure 14. Female Sexual Dysfunction Treatment Report Years Considered

Figure 15. Global Female Sexual Dysfunction Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Female Sexual Dysfunction Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Female Sexual Dysfunction Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Female Sexual Dysfunction Treatment Market Share by Players in 2023

Figure 19. Global Top Female Sexual Dysfunction Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Sexual Dysfunction Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Female Sexual Dysfunction Treatment Revenue in 2023

Figure 21. North America Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Female Sexual Dysfunction Treatment Market Share by Country (2019-2030)

Figure 23. United States Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Female Sexual Dysfunction Treatment Market Share by Country (2019-2030)

Figure 27. Germany Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Female Sexual Dysfunction Treatment Market Share by Region (2019-2030)

Figure 35. China Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Female Sexual Dysfunction Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Female Sexual Dysfunction Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. AMAG Pharmaceuticals Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2019-2024)

Figure 50. Duchesnay Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2019-2024)

Figure 51. Emotional Brain BV Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2019-2024)

Figure 52. Novo Nordisk AS Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2019-2024)

Figure 53. Sprout Pharmaceuticals Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Latex Free Ultrasound Probe Cover Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1F15730

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global In Vitro Skin Model Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39J16107

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

Global Digital Video Colposcope Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27W12034

Sun Aug 25 00:00:00 UTC 2024

Add to Cart

Global Sperm Quality Analyzer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-17J15686

Sun Aug 25 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions